☰

Robert B. Campbell, PhD - Publications

Affiliations: 
Biophysics Roswell Park Cancer Institute, Buffalo, NY, United States 
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sanghvi KS, Campbell R, Yan G. Abstract 3629: Development of Combrestatin loaded vascular cell modified CLENS for targeting cellular models of tumor vascular endothelia in vitro Cancer Research. 79: 3629-3629. DOI: 10.1158/1538-7445.Am2019-3629  0.443
2018 Alharbi HM, Campbell RB. Nano-formulations composed of cell membrane-specific cellular lipid extracts derived from target cells: physicochemical characterization and in vitro evaluation using cellular models of breast carcinoma Aaps Open. 4: 1-9. DOI: 10.1186/S41120-018-0025-1  0.427
2018 Alharbi HM, Campbell RB. Abstract 4666: An evaluation of breast cancer cellular membrane lipid-extracted nanoliposomes (CLENs) in relation to formulation design, stability, mechanism of cellular entry and cardioprotective function in vitro Cancer Research. 78: 4666-4666. DOI: 10.1158/1538-7445.Am2018-4666  0.437
2018 Omaer A, Alqarni A, Randulfe C, Alharbi H, Campbell R. Abstract 3881: Formulating a cell membrane lipid-extracted nanoliposome (CLENS) drug platform for the treatment of prostate cancer Cancer Research. 78: 3881-3881. DOI: 10.1158/1538-7445.Am2018-3881  0.416
2017 Richards SM, Campbell RB. Piloting Your Nanovehicle to Overcome Biological Barriers. Methods in Molecular Biology (Clifton, N.J.). 1530: 139-145. PMID 28150201 DOI: 10.1007/978-1-4939-6646-2_9  0.314
2017 Sahakyan N, Haddad A, Richardson S, Forcha-Etieundem V, Christopher L, Alharbi H, Campbell R. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision. Anti-Cancer Agents in Medicinal Chemistry. PMID 28042778 DOI: 10.2174/1871520617666170102150730  0.363
2016 Alkholief M, Campbell RB. Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: An in vitro study. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 26961466 DOI: 10.1016/J.Nano.2016.01.007  0.386
2015 Alqahtani TY, Campbell R. Abstract 5528: Development and evaluation of cell membrane lipid-extracted nanoliposomes (CLENs) for the treatment of cancer using cellular models of human pancreatic cancer Cancer Research. 75: 5528-5528. DOI: 10.1158/1538-7445.Am2015-5528  0.437
2015 Alharbi HM, Campbell RB. Abstract 5513: Employing a unique panel of breast cancer cellular lipids extracts in the development of a novel nanoliposome drug platform Cancer Research. 75: 5513-5513. DOI: 10.1158/1538-7445.Am2015-5513  0.385
2015 Richards SM, Campbell RB. Abstract 4554: An evaluation of the role of Mucin in drug resistant ovarian cancer Cancer Research. 75: 4554-4554. DOI: 10.1158/1538-7445.Am2015-4554  0.338
2014 Ying B, Campbell RB. Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature. Biochemical and Biophysical Research Communications. 446: 441-7. PMID 24607899 DOI: 10.1016/J.Bbrc.2014.02.120  0.397
2014 Cheng S, Crall W, Nguyen B, Dang C, Alkholief M, Campbell RB. Abstract 4473: Development of ceramide liposomes for tumor interstitial and vascular drug targeting Cancer Research. 74: 4473-4473. DOI: 10.1158/1538-7445.Am2014-4473  0.431
2014 Alkholief MA, Campbell R. Abstract 4469: An evaluation of the role of mucin in nano drug delivery Cancer Research. 74: 4469-4469. DOI: 10.1158/1538-7445.Am2014-4469  0.402
2011 Sridhar S, Campbell R, Nagesha D, Gultepe E. Abstract 380: Magnetic nanoplatforms for tumor targeting, imaging and energy delivery Cancer Research. 71: 380-380. DOI: 10.1158/1538-7445.Am2011-380  0.339
2010 Gultepe E, Reynoso FJ, Jhaveri A, Kulkarni P, Nagesha D, Ferris C, Harisinghani M, Campbell RB, Sridhar S. Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine (London, England). 5: 1173-82. PMID 21039195 DOI: 10.2217/Nnm.10.84  0.334
2010 Kuesters GM, Campbell RB. Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential. Nanomedicine (London, England). 5: 181-92. PMID 20148631 DOI: 10.2217/Nnm.09.105  0.396
2010 Reynoso F, Gultepe E, Jhaveri A, Kulkarni P, Gershman B, Ferris C, Campbell R, Harisinghani M, Sridhar S. TH-D-201C-08: Multi-Modal MRI SPECT and CT Imaging of Theranostic Nanoplatforms Medical Physics. 37: 3470-3470. DOI: 10.1118/1.3469556  0.329
2009 Dandamudi S, Patil V, Fowle W, Khaw BA, Campbell RB. External magnet improves antitumor effect of vinblastine and the suppression of metastasis. Cancer Science. 100: 1537-43. PMID 19459849 DOI: 10.1111/J.1349-7006.2009.01201.X  0.388
2009 Kalra AV, Campbell RB. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. European Journal of Cancer (Oxford, England : 1990). 45: 164-73. PMID 19046630 DOI: 10.1016/J.Ejca.2008.10.008  0.326
2009 Campbell RB, Ying B, Kuesters GM, Hemphill R. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics. Journal of Pharmaceutical Sciences. 98: 411-29. PMID 18563780 DOI: 10.1002/Jps.21458  0.412
2008 Dabbas S, Kaushik RR, Dandamudi S, Kuesters GM, Campbell RB. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells. Endothelium : Journal of Endothelial Cell Research. 15: 189-201. PMID 18663622 DOI: 10.1080/10623320802228583  0.428
2007 Kalra AV, Campbell RB. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. British Journal of Cancer. 97: 910-8. PMID 17912239 DOI: 10.1038/Sj.Bjc.6603972  0.341
2007 Dandamudi S, Campbell RB. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials. 28: 4673-83. PMID 17688940 DOI: 10.1016/J.Biomaterials.2007.07.024  0.389
2007 Dandamudi S, Campbell RB. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Biochimica Et Biophysica Acta. 1768: 427-38. PMID 17258172 DOI: 10.1016/J.Bbamem.2006.10.006  0.357
2006 Campbell RB. Tumor physiology and delivery of nanopharmaceuticals. Anti-Cancer Agents in Medicinal Chemistry. 6: 503-12. PMID 17100555 DOI: 10.2174/187152006778699077  0.374
2006 Kalra AV, Campbell RB. Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting. Pharmaceutical Research. 23: 2809-17. PMID 17066329 DOI: 10.1007/S11095-006-9113-3  0.386
2004 Alexandrakis G, Brown EB, Tong RT, McKee TD, Campbell RB, Boucher Y, Jain RK. Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors. Nature Medicine. 10: 203-7. PMID 14716306 DOI: 10.1038/Nm981  0.337
2002 Balasubramanian SV, Campbell RB, Straubinger RM. Propofol, a general anesthetic, promotes the formation of fluid phase domains in model membranes. Chemistry and Physics of Lipids. 114: 35-44. PMID 11841824 DOI: 10.1016/S0009-3084(01)00199-2  0.562
2001 Campbell RB, Balasubramanian SV, Straubinger RM. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. Journal of Pharmaceutical Sciences. 90: 1091-105. PMID 11536214 DOI: 10.1002/Jps.1063  0.599
2001 Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, Jain RK. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nature Medicine. 7: 864-8. PMID 11433354 DOI: 10.1038/89997  0.333
2001 Campbell RB, Balasubramanian SV, Straubinger RM. Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochimica Et Biophysica Acta. 1512: 27-39. PMID 11334622 DOI: 10.1016/S0005-2736(01)00290-5  0.603
2001 Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, Brown EB, Izumi Y, Campbell RB, Berk DA, Jain RK. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proceedings of the National Academy of Sciences of the United States of America. 98: 4628-33. PMID 11274375 DOI: 10.1073/Pnas.081626898  0.327
Show low-probability matches.